Abiopharma

CAPLYTA® (lumateperone) showed greatest improvement across key efficacy outcomes among adjunctive MDD treatments in new network meta-analysis

JLens Urges Meta Shareholders to Vote FOR Proposal 8 at the Company’s Annual Meeting on May 27, 2026

WEX and Impactive Capital Announce Cooperation Agreement

DuPont Publishes 2026 Sustainability Report

Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022684 <b>Size:</b> 736 KB

Director McClintock William 🟢 acquired 52 shares (1 derivative) of T Stamp Inc (IDAI) Transaction Date: Apr 30, 2026 | Filing ID: 000012

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011893 <b>Size:</b> 612 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011892 <b>Size:</b> 656 KB

Director Potts Charles Edward 🟢 acquired 1.2K shares (1 derivative) of T Stamp Inc (IDAI) Transaction Date: Apr 30, 2026 | Filing ID: 000010

(99% Neutral) RALLYBIO CORP (RLYB) Announces Business Combination

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001918704-26-011891 <b>Size:</b> 624 KB

RITHM CAPITAL CORP. (RITM) Files Form 10-Q

New Form 424B2 - UBS AG <b>Filed:</b> 2026-05-04 <b>AccNo:</b> 0001839882-26-022679 <b>Size:</b> 675 KB

Director Teoh Pui Pui 🟢 acquired 1.5M shares of Mobile-health Network Solutions (MNDR) Transaction Date: Apr 30, 2026 | Filing ID: 021016